Results 51 to 60 of about 123 (118)

Clinicopathological and molecular characterization of HPV‐associated cervical poorly cohesive carcinoma: a rare aggressive entity

open access: yesThe Journal of Pathology: Clinical Research, Volume 12, Issue 4, July 2026.
Abstract Primary signet‐ring cell carcinoma and poorly differentiated adenocarcinoma with poorly cohesive morphology in the cervix are rare conditions, and their clinicopathological features remain poorly described. This study defines primary cervical poorly differentiated adenocarcinomas meeting the diagnostic criteria for poorly cohesive carcinoma as
Wei Liu   +14 more
wiley   +1 more source

Reconstructing the Past and the Present: The Ethnographic Films Made by the Estonian National Museum (1961–1989)

open access: yesJournal of Ethnology and Folkloristics, 2011
This article analyses the films made by the Estonian National Museum in the 1970s and the 1980s both from the point of view of the filming activity and of the content of these films.
Liivo Niglas, Eva Toulouze
doaj  

Can Multiple Sclerosis be Managed Over a Lifetime? A Rare 72‐Year Journey of Pediatric‐Onset to Secondary Progressive Multiple Sclerosis

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Multiple sclerosis (MS) is a chronic demyelinating disorder of the central nervous system characterized by cumulative neurological disability over time. Median survival from symptom onset in large cohort studies is approximately four decades, although substantially prolonged disease courses are uncommon.
Masoud Etemadifar   +4 more
wiley   +1 more source

Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro‐Inflammatory Responses via Modulation of JNK and NFkB Signaling

open access: yesGlia, Volume 74, Issue 7, July 2026.
SNPs in SH3RF3 decrease the age of onset of Alzheimer's disease (AD). Reduced SH3RF3 blunts human microglial JNK and NFkB signaling and downstream inflammatory cytokine production, which may partially explain how SH3RF3 SNPs protect against AD. ABSTRACT Understanding how high‐risk individuals are protected from Alzheimer's disease (AD) may illuminate ...
Ronak Patel   +13 more
wiley   +1 more source

First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT This guideline summarizes diagnostic and therapeutic approaches based on a systematic literature review and evidence evaluation using the GRADE methodology. Given the limited high‐quality data, expert consensus was additionally obtained through a modified Delphi process.
Giorgia Olivieri   +26 more
wiley   +1 more source

FUTURUM-EXACTUM: A VERB FORM OF WRITTEN VEPSIAN THAT IS NOT TAKEN INTO ACCOUNT IN ITS DESCRIPTIONS

open access: yesYearbook of Finno-Ugric Studies, 2021
The article discusses the use of an analytical verb form of the linneb tehtud type in written Vepsian, that consists the 3 person singular form of the verb linneb ‘will’ and the passive past participle on -tud/-dud (in most cases) and is a calque from a similar Russian construction будет сделан (-a, -o).
openaire   +2 more sources

Integrating Functional Consequence Annotation With PAH Allelic Phenotype Values Refines Prediction of Tetrahydrobiopterin Responsiveness

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT Tetrahydrobiopterin (BH4; sapropterin) responsiveness in phenylalanine hydroxylase (PAH) deficiency is genotype dependent, yet many patients remain untested. Allelic phenotype values (APV) summarize allele severity, but responsiveness can be heterogeneous within APV strata. We assessed whether integrating functional consequence annotation from
Nastassja Himmelreich, Nenad Blau
wiley   +1 more source

Cyrillic in the Geolinguistic Space. [PDF]

open access: yesHer Russ Acad Sci, 2022
Aref'ev AL.
europepmc   +1 more source

A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB–IIIB Lung Squamous Cell Carcinoma

open access: yesMedComm, Volume 7, Issue 7, July 2026.
This phase II trial suggests the potential of perioperative camrelizumab plus neoadjuvant chemotherapy in patients with resectable stage IIB‐IIIB lung squamous cell carcinoma. The major pathological response rate (primary endpoint) was 60.0%, and the pathological complete response (pCR) rate was 44.4%.
Mingming Hu   +17 more
wiley   +1 more source

Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia. [PDF]

open access: yesGenes (Basel), 2022
Dzhaubermezov M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy